Sema3f Protects Against Subretinal Neovascularization In Vivo

Ye Sun(Boston Children's Hospital), Andreas Stahl(University Medical Center Freiburg), Chi‐Hsiu Liu(Boston Children's Hospital), Hansjürgen Agostini(University of Freiburg), Samuel Burnim(Boston Children's Hospital), Daniel Böhringer(University Medical Center Freiburg), Yan Gong(Guizhou University of Finance and Economics), Tristan Reuer(University of Freiburg), Raffael Liegl(Boston Children's Hospital), Lois E. H. Smith(Boston Children's Hospital), Peipei Zhang(Zhejiang Chinese Medical University), Clemens Lange(University of Freiburg), Steven Meng(Boston Children's Hospital), Anima Bühler(University of Freiburg), Johanna M. Walz(University of Freiburg), Franziska Ludwig(University of Freiburg), Bertan Cakir(Boston Children's Hospital), Günther Schlunck(University Medical Center Freiburg)
EBioMedicine
March 21, 2017
10.1016/j.ebiom.2017.03.026
Cited by 28

Related Papers

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k
Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor
|Diabetes|1997|669
Consensus guidelines for the use and interpretation of angiogenesis assays
|Angiogenesis|2018|602
Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
|Proceedings of the National Academy of Sciences|1996|344